Hyalornic Acid Level in β-Thalassemic Children Treated for Hepatitis C Virus
Status:
Completed
Trial end date:
2019-03-01
Target enrollment:
Participant gender:
Summary
Patients with transfusion dependent Beta Thalassemia suffer from a high incidence of
Hepatitis C infection especially in developed countries as Egypt. In our patients we also
found a high correlation between hepatitic C infection and Liver fibrosis. in this study we
offer our patients treatment with Direct antiviral drugs and assessed the degree of fibrosis
before and after treatment. We tested Hyalornic acid as a predictor of the degree of fibrosis
before and after treatment.
Phase:
Phase 4
Details
Lead Sponsor:
Tanta University
Treatments:
Ledipasvir Ledipasvir, sofosbuvir drug combination Sofosbuvir